Interaction of Heparin with Histidine-Rich Glycoprotein and with Antithrombin III

Summary

The interaction between heparin, histidine-rich glycoprotein and antithrombin III was studied in purified systems. Histidine- rich glycoprotein binds heparin and thereby interferes with its interaction with antithrombin III, resulting in neutralization of the anticoagulant activity. This interaction occurs with clinical grade heparin as well as with high affinity (for antithrombin III) heparin and with a high affinity heparin fragment with M_r. 4,300.

Low affinity heparin competes with high affinity heparin for the binding to histidine-rich glycoprotein which results in an apparent increase of the anticoagulant activity of high affinity heparin.

The interaction between heparin and histidine-rich glycoprotein is counteracted by Ca²⁺-binding anticoagulants, indicating that it is dependent on the presence of divalent metal ions. Ethylenediaminetetraacetate is a much more potent inhibitor of the interaction between heparin and histidine-rich glycoprotein than citrate.

Keywords

Heparin - Histidine-rich glycoprotein - Anticoagulant activity

• References

• 1 Lijnen HR, Rylatt DB, Collen D. Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factor. Biochim Biophys Acta 1983; 742: 109-115
• 2 Heimburger N, Haupt H, Kranz T, Baudner S. Humanserumprotein mit hoher Affinität zu Carboxymethylcellulose. II. Physikalischchemische und immunologische Charakterisierung eines histidinreichen 3,8 S-α₂-Glykoproteins (CM-Protein I). Hoppe-Seyler’s Z Physiol Chem 1972; 353: 1133-1140
• 3 Lijnen HR, Jacobs G, Collen D. Histidine-rich glycoprotein in a normal and a clinical population. Thromb Res 1981; 22: 519-523
• 4 Koide T, Odani S, Ono T. The N-terminal sequence of human plasma histidine-rich glycoprotein homologous to antithrombin with high affinity for heparin. FEBS Lett 1982; 141: 222-224
• 5 Lijnen HR, Hoylaerts M, Collen D. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma J Biol Chem 1983; 258: 3803-3808
• 6 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine-binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein J Biol Chem 1980; 255: 10214-10222
• 7 Morgan WT. Interactions of the histidine-rich glycoprotein of serum with metals. Biochemistry 1981; 20: 1054-1061
• 8 Rylatt DB, Sia DY, Mundy JP, Parish CR. Autorosette inhibition factor: isolation and properties of the human plasma protein. Eur J Biochem 1981; 119: 641-646
• 9 Lijnen HR, Hoylaerts M, Collen D. Neutralization of heparin activity by binding to human histidine-rich glycoprotein. Thromb Res 1983; 29: 443-446
• 10 Olson ST, Shore JD. Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement. J Biol Chem 1981; 256: 11065-11072
• 11 Jordon R, Beeler D, Rosenberg R. Fractionation of low molecular weight heparin species and their interaction with antithrombin. J Biol Chem 1979; 254: 2909-2913
• 12 Miller-Anderson M, Borg H, Andersson L-O. Purification of antithrombin III by affinity chromatography. Thromb Res 1974; 5: 439-452
• 13 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 14 Andersson L-O, Barrowcliffe TW, Holmer E, Johnson EA, Sims GE. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575-583
• 15 Lindahl U, Bäckström G, Höök M, Thunberg L, Fransson L-A, Linker A. Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci USA 1979; 76: 3198-3202